Cannabis was slowly but surely introduced to the market because to the 2018 Farm Bill. It all began with CBD, which swiftly gained acceptance as a therapeutic alternative. Now that we have CBG, CBN, THCV, delta 8, delta 10, HHC, and other compounds, we can no longer keep up. What CBC is, what it does, why it’s unique, and how to get it are all explained here.

Click here for more information.


Cannabichromene, also known as CBC, is the third most prevalent cannabinoid in cannabis. In terms of potency, it ranks right up there with CBD and THC. All three cannabinoids originate from CBG, albeit most of it is converted to CBD or THC in hemp and marijuana. Although growers have historically developed these plants for high quantities of CBD and THC, respectively, despite the fact that we have known about CBC for decades — since 1966, to be exact —

We currently have a resurgence of interest in cannabinoids like CBC and their effects on the human body, thanks to the Farm Bill or even the discovery of the endocannabinoid system. This goal has caused breeders to refocus their efforts on creating new cannabis strains that are high in CBC. Realistically, any quantifiable results won’t be available for a few more years. For the time being, CBC is extracted from hemp plants and concentrated using distillation and chromatography.


The following information would be meaningless to you without a science dictionary and plenty of free time unless you are an expert in the field or have a strong interest in it.

Even though we don’t have all the information, we present this material to provide context for CBC’s potential. What the research has so far shown is as follows:

The transient receptor potential ankyrin-1 is activated by CBC, which prevents endocannabinoid inactivation.

A selective CB2 agonist is CBC.

The TRP cation channels that CBC interacts with are TRPA1, TRPV1-4, and TRPV8.

CB1 cells are not hyperpolarized, while CB2 cells are triggered by CBC in a dose-dependent manner.

Without the involvement of GRK2/3 kinases, CBC signals through Gi/o type G proteins to promote CB2 receptor internalisation.

The next part elaborates and clarifies some of these points.


No, CBC is not psychoactive, therefore consuming any amount of it won’t make you feel high.

The high that is related to marijuana is produced when THC binds to the CB1 receptor. You cannot get high on CBC because it does not affect the CB1 receptor.

Similar to CBD, the effects are significantly more engaged in mood and overall homeostasis maintenance (a fancy word for balance).


Yes, thanks to the 2018 Farm Bill, hemp-derived CBC is now legal in the US.

However, confirm the remaining ingredients before making a purchase. It’s common for businesses to combine delta 8 THC or delta 9 THC with CBC goods because to how well these cannabinoids interact with one another.


There is currently no evidence that CBC is hazardous. Studies using high doses of CBC showed a remarkably low incidence of adverse effects.

Because hemp-derived cannabinoids are similar to THC and CBD, researchers use the knowledge on THC and CBD to assess the safety profile of CBC.

Marijuana has some undesirable effects and dangers (short-term memory loss, drug interactions, anxiety, etc.). However, it is generally safe and the advantages outweigh the disadvantages, especially when compared to other prescription medications.

They are more comparable because neither CBC nor CBD act as antagonists to CB receptors but rather have different effects on them. The cannabinoid CBD is secure, well-tolerated, and has demonstrated extraordinary potential in some areas.

Leave a Reply